A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued separate voluntary U.S. drug recalls in recent weeks due to either the presence of ...

Sun Pharma launches Unloxcyt (cosibelimab-ipdl) in the US for skin cancer treatment. Available for advanced cutaneous ...

Sun Pharma's SPARC reduces workforce by 40%, consolidating operations and shifting to a hybrid research model for efficiency.

Agreed Price of US$43.00 per Share to Deliver 48% Premium to Unaffected Price on May 25, 2023 Dilip Shanghvi, Managing Director of Sun Pharma, said, "Over the years, with Sun Pharma's strategic ...

Ascroft succeeds Abhay Gandhi. According to a June 25 hiring announcement from the the India-based parent company Gandhi, “played a pivotal role in the growth of the Sun Pharma North America business.

Mumbai: The Bombay High Court has set aside the interim injunction granted earlier in the trademark infringement and ...

PRINCETON, N.J., Oct. 22, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma ...

ET NOW Global Business Summit, ET NOW GBS: Dilip Shanghvi, Founder & Managing Director, Sun Pharmaceutical Industries, on Saturday dropped hints that the company could look to split its business in ...

Sun Pharmaceutical Industries Ltd, the country’s largest drugmaker by revenue and market value, has slipped behind the Sensex and Nifty in 2025 — its first spell of underperformance in six years. The ...

Sun Pharma and Taro have entered into a definitive merger agreement in which Sun Pharma, Taro's controlling shareholder, has agreed to acquire all of the outstanding ordinary shares of Taro other than ...